Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
Phase 2
40
about 1.6 years
18–65
2 sites in DC, MD
What this study is about
This trial is testing whether semaglutide is safe and well-tolerated in adults with cocaine use disorder, both with and without HIV. Participants will receive either semaglutide or a placebo for 601 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Semaglutide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
semaglutide (GLP-1 agonist; stimulates insulin release)
oral (Oral Tablet)
Primary: Tolerability of semaglutide in patients with cocaine use disorder (CUD) with and without HIV
Immune, Infectious